Company
Kiyatec
Founded
2007
3D Predict is revolutionizing cancer care.
Kiyatec is a functional precision oncology company that uses a patient’s own living cancer cells to predict their response to specific chemotherapy and targeted agents. Their Predict™ platform creates a culture of the patient's tumor to test various therapies, providing clinically relevant evidence to help oncologists make informed treatment decisions.